Log in to save to my catalogue

Cornerstones of CRISPR–Cas in drug discovery and therapy

Cornerstones of CRISPR–Cas in drug discovery and therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1868335792

Cornerstones of CRISPR–Cas in drug discovery and therapy

About this item

Full title

Cornerstones of CRISPR–Cas in drug discovery and therapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Drug discovery, 2017-02, Vol.16 (2), p.89-100

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
CRISPR–Cas tools are easily programmable RNA-guided nucleases that are derived from microbial adaptive immune systems and enable rapid genome engineering
in vitro
and
in vivo
.
Paired with the rapid expansion of genomic information, CRISPR–Cas enables facile genetic manipulation, even in previously difficult contexts su...

Alternative Titles

Full title

Cornerstones of CRISPR–Cas in drug discovery and therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1868335792

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1868335792

Other Identifiers

ISSN

1474-1776

E-ISSN

1474-1784

DOI

10.1038/nrd.2016.238

How to access this item